Subscribe

Main navigation

Home
Conferences
2026 Washington, DC
2026 London
2025 Berlin
2024 Athens
2023 New York City
CME
Spotlight
Studies
Media
About
About SEGM
FAQ
Our Response to the SPLC
Contact
Grant Opportunities
Support

Search results

The Evidence to Support Medicalised Gender Transitions in Adolescents is Worryingly Weak

April 14, 2023
Spotlight
Prisha Mosley was 17 when she was first given testosterone in a clinic in North Carolina, after she had declared to her parents that she was a boy. She had struggled through her teen years with anorexia and depression after a sexual assault. Luka Hein had both breasts removed as a 16-year-old in...
Matched fragments:
… She had been on testosterone and puberty-blocking drugs since 13, … some of them a combination of puberty-blocking drugs, opposite-sex … teenagers were prescribed puberty-blockers or cross- sex hormones in …

Critical Appraisal of “Long-Term Regret and Satisfaction With Decision Following Gender-Affirming Mastectomy”

August 13, 2023
Spotlight

Recent research published in JAMA Surgery evaluated satisfaction and regret among individuals who had undergone...

Matched fragments:
…  that claimed that access to puberty blockers reduce the risk of suicide … that individuals reporting use of puberty blockers use had twice as …

The Cass Review and Gender-Related Care for Young People in Canada: A Commentary on the Canadian Paediatric Society Position Statement on Transgender and Gender-Diverse Youth

November 21, 2025
Studies

In this peer-reviewed publication Chan Kulatunga Moruzi and colleagues raise substantial concerns about the 2023 Canadian Paediatric Society Position Statement (CPS-PS), “An...

Matched fragments:
… physicians need to know about puberty blockers (PBs) and gender-affirming … benefits and understates risks of puberty blockers and hormone therapy. …

Gender-affirming care for transgender and gender-diverse youth in Oregon: trends over time

April 9, 2026
Studies
Background and Aims Despite increasing attention, population-level evidence on medical gender-affirming care (GAC) used among transgender and gender-diverse (TGD) adolescents remains limited, and little is known about use in supportive policy environments. To describe population-level patterns and...
Matched fragments:
… dysphoria and assessed receipt of puberty blockers and gender-affirming … received medical GAC (8% puberty blockers; 20% hormone …

"Gender-affirming" Hormones and Surgeries for Gender-Dysphoric US Youth

May 28, 2021
Spotlight
Following the 60 Minutes episode earlier this week, which highlighted the controversies surrounding medical interventions for gender dysphoric youth, SEGM has been receiving an increasing number of inquiries about the state of gender care for youth in the United States. One question in particular...
Matched fragments:
… appeared for the first time after puberty were considered at a high … Dutch protocol (the sequence of puberty blockade, cross-sex-hormones … The provision of puberty blockers, cross-sex-hormones, or …

YOUTH GENDER DISTRESS

Conferences
SEGM 2025 Berlin Conference: Welcoming Address by Dr. Klaus Reinhardt

Our Berlin conference brought together researchers, clinicians, and academics from more than 20 countries, representing a range of specialties and viewpoints. With over 40 speakers, the event facilitated thoughtful discussion and debate on how to understand and support gender-dysphoric young people.

The Youth Gender Distress conference has been endorsed by the International Association of Child and Adolescent Psychiatry and Allied Professions (IACAPAP).
Matched fragments:
… Evidence Reviews for Puberty Blockers, Hormones, and Surgeries … to discover the experiment with puberty blockers conducted by the … gender-dysphoric youth with puberty blockers and cross-sex …

Letter to the Editor: “Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline”

March 1, 2019
Studies
Childhood gender dysphoria (GD) is not an endocrine condition, but it becomes one through iatrogenic puberty blockade (PB) and high-dose cross-sex (HDCS) hormones. The consequences of this gender-affirmative therapy (GAT) are not trivial and include potential sterility, sexual dysfunction,...
Matched fragments:
… it becomes one through iatrogenic puberty blockade (PB) and high-dose …

In Support of Research Into Rapid-Onset Gender Dysphoria

January 1, 2020
Studies

A group of clinicians extensively working with gender dysphoric youth confirm the emergence of a phenomenon that as been described as "adolescent-onset gender dysphoria," "rapid onset gender dysphoria," as well as several other terms.

They note, "while there is an ongoing debate about how...

Matched fragments:
… to or during the early stages of puberty (certainly nothing of …

Accurate transition regret and detransition rates are unknown

September 11, 2023
Spotlight

Like all medical interventions, “gender-affirming” interventions are associated with a range of physical and mental health outcomes—both positive and negative. Regret and detransition are examples of negative outcomes. Proponents of youth gender transition assert that rates of regret and...

Matched fragments:
… a mix of interventions (including puberty blockers, hormones, and/or … 17,000 children aged 6–17 started puberty blockers or hormones from …

The Detransition Rate Is Unknown

July 1, 2023
Studies

Like all medical interventions, “gender-affirming” interventions are associated with a range of physical and mental health outcomes—both positive and negative. Regret and detransition are examples of negative outcomes. Proponents of youth gender transition assert that rates of regret and...

Matched fragments:
… is medical intervention (i.e., puberty blockers, hormones, and/or … a mix of interventions (including puberty blockers, hormones, and/or …

Pagination

  • First page « First
  • Previous page ‹
  • …
  • Page 7
  • Page 8
  • Current page 9
  • Page 10
  • Page 11
  • …
  • Next page ›
  • Last page Last »

SEGM is committed to safeguarding scientific integrity through open discourse and collaboration. Researchers and clinicians worldwide must be free to pursue scientific inquiry without censorship or intimidation.

Our Response to the SPLC
FAQs about SEGM
Close

Society for Evidence-Based Gender Medicine

© 2020-2026 SEGM